ADDTECH AB 
By Addtech Life Science, a business area in the Addtech Group, has today acquired all shares outstanding in BioNordika Holding AB.
BioNordika Holding AB is the parent company of the BioNordika Group, which has subsidiaries in Denmark, Estonia, Finland, Norway and Sweden. The BioNordika Group markets reagents and instruments for biomedical research, mainly in the pharmaceutical industry and at public institutions. The Group has a strong position in the Nordic market and represents leading suppliers in areas such as cell and molecular biology as well as immunology and diagnostics. The BioNordika Group has 24 employees and sales of around SEK 80 million.
The BioNordika Group will very effectively complement Addtech's operations in the Diagnostic business unit. The business unit focuses on sales of reagents and equipment for healthcare laboratories in the Nordic region.
The closing will take place today and the acquisition is estimated to have a marginally positive effect on Addtech's earnings per share during the current financial year.
Stockholm, 26 January 2012
Addtech AB (publ)
For more information, please contact
Johan Sjö, President, Addtech AB, +46 8 470 49 00
Artur Aira, Business Area Manager, Addtech Life Science, +46 8 54 54 14 00
http://hugin.info/132861/R/1579952/493433.pdf
The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and other applicable laws; and
(ii) they are solely responsible for the content, accuracy and originality of the
information contained therein.
Source: Addtech AB via Thomson Reuters ONE
